• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Thursday, January 21, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

AIIMS planning to conduct clinical trial of plasma therapy

NE NOW NEWS by NE NOW NEWS
NEW DELHI , April 29, 2020 2:07 pm
AIIMS MBBS Result 2019

AIIMS, Delhi

Share on FacebookShare on Twitter

All India Institute of Medical Sciences (AIIMS) director Randeep Guleria on Wednesday said convalescent plasma therapy as a potential cure for coronavirus is still at ‘an experimental stage’ and there is a need for good clinical trials before it can be recommended for routine use of coronavirus patients.

He also said AIIMS is planning to conduct a clinical trial on the efficacy of convalescent plasma therapy in COVID-19 patients.

Guleria also said that the institute is working with the Indian Council of Medical Research (ICMR) and the Drug Controller General of India whose approvals are necessary for conduction of proper clinical trials.

He claimed that only some studies have shown convalescent plasma therapy to give some signs of improvement to COVID-19 patients.

“In very limited studies, globally, convalescent plasma as an adjunct to other supportive therapies and treatments has shown some benefit in the management of severe patients of COVID-19,” Guleria said.

The AIIMS director also claimed that plasma has to be first tested on whether it has sufficient antibodies and is safe and useful to be administered to a COVID-19 patient.

“Giving plasma from a recovered patient without testing whether it has enough antibody titer or not may cause more harm than good as it can cause transfusion-related reactions,” he said.

Guleria’s statement comes after a private hospital in Delhi claimed to have successfully cured a 49-year-old COVID-19 patient with plasma therapy.

The hospital had also discharged the man last week.

Tags: COVID19
Joe Biden

Joe Biden, Kamala Harris take took oath as US President, Vice President

NITI

Manipur bags third position, Sikkim slips down to 4th position in India Innovation Index 2020

Brahmaputra diversion

Diversion of Brahmaputra water by China shall act as an encroachment: Central Water Commission

Atul Bora

Assam Assembly polls 2021: AGP president Atul Bora slams pre-poll alliance of Congress, AIUDF

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd